Covestor’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Covestor's EDIT Position: Q3 2026 in Review
Covestor reduced its Editas Medicine (EDIT) stake by 40% in Q3 2026, selling an estimated $126 and leaving 65 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2474.
Covestor first reported a position in EDIT in Q4 2021 and has held it in 20 quarters since. The position peaked at $28K in Q1 2022. 162 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Covestor held 65 shares of Editas Medicine worth $0 as of Q3 2026.
- Covestor sold 43 Editas Medicine shares in Q3 2026, an estimated $126.
- Editas Medicine made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2474 holding.
- Covestor first reported a position in Editas Medicine in Q4 2021 and has held it in 20 quarters since.
- Covestor's Editas Medicine position peaked at $28K in Q1 2022.
- 162 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.